Literature DB >> 34269171

Health technology assessment applied to emergency preparedness: a new perspective.

Alessandro Miglietta1, Chiara de Waure2,3, Catherine Chronaki4, Claudia Wild5, Carlo Favaretti2, Aura Timen1,6,7, Michael Edelstein1, Elena Petelos1,2,8,9.   

Abstract

Emergency preparedness is a continuous quality improvement process through which roles and responsibilities are defined to effectively anticipate, respond to, and recover from the impact of emergencies. This process results in documented plans that provide a backbone structure for developing the core capacities to address health threats. Nevertheless, several barriers can impair an effective preparedness planning, as it needs a 360° perspective to address each component according to the best evidence and practice. Preparedness planning shares common principles with health technology assessment (HTA) as both encompass a multidisciplinary and multistakeholder approach, follow an iterative cycle, adopt a 360° perspective on the impact of intervention measures, and conclude with decision-making support. Our "Perspective" illustrates how each HTA domain can address different component(s) of a preparedness plan that can indeed be seen as a container of multiple HTAs, which can then be used to populate the entire plan itself. This approach can allow one to overcome preparedness barriers, providing an independent, systematic, and robust tool to address the components and ensuring a comprehensive evaluation of their value in the mitigation of the impact of emergencies.

Keywords:  COVID-19; Emergency preparedness; Health technology assessment; Outbreak control

Year:  2021        PMID: 34269171     DOI: 10.1017/S0266462321000465

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  1 in total

1.  "Long COVID" results after hospitalization for SARS-CoV-2 infection.

Authors:  Marta Rigoni; Emanuele Torri; Giandomenico Nollo; Livia Delle Donne; Sebastiano Rizzardo; Lorenza Lenzi; Andrea Falzone; Susanna Cozzio
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.